Fingerprint
Dive into the research topics of 'Phase i study of S-trans, trans-farnesylthiosalicylic acid (Salirasib), a novel oral RAS inhibitor in patients with refractory hematologic malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically